Brenus Pharma
My visitor profile
Brenus Pharma
Description of your activity
-
Brenus Pharma is a French clinical-stage biotech developing a pioneering discovery platform ; Stimulated-Tumor-Cell (STC) generating the new generation of proteomic-driven immunotherapies.
STCs educate patient’s immune system to give them back the ability to target and destroy evolving tumor cells.
Brenus Pharma is on the brink of a breakthrough and will start its First in Human study in 2024 in colorectal cancer in 9 top oncology centers (US/EU)
More information
Participation objectives
Partnering objectives
- Network development